Post by Jatin Mahajan
India’s Diagnostics Institution Builder | President, ADMI | MD, J Mitra & Co. | Advancing Indigenous IVD Innovation for Bharat & Global Markets
‼️‼️The lab that wins tomorrow may not be the lab with the largest machine‼️‼️ It may be the lab that gives the doctor the earliest reliable direction. Rapid infectious disease testing is no longer a “small test counter” business. For dengue, malaria, HIV, HCV, syphilis and respiratory infections, speed is not a convenience. It is clinical leverage. In India, fever is rarely simple. A patient walks in with body ache, chills, cough, weakness or persistent fatigue. The doctor is not looking for a report after the opportunity is lost. The doctor is looking for direction when the patient is still sitting in front of them. Is it dengue? Is it malaria? Is it influenza? Is it COVID? Is there HIV, HCV or syphilis risk that needs immediate counselling and next-step testing? Every delayed answer creates repeat visits, anxiety, empirical treatment, avoidable referrals and sometimes missed diagnosis. This is where rapid testing creates value. Not by replacing ELISA, CLIA, PCR or confirmatory algorithms. But by creating the first disciplined layer of decision-making. For a pathology business owner, rapid infectious testing should not be treated as a low-value add-on. It should be designed as a serious clinical workflow. The opportunity is not just selling kits. The opportunity is building trust through: sample timing, trained staff, clear reporting language, reflex testing pathways, doctor education, quality control, and responsible interpretation. A rapid test done casually can damage trust faster than a delayed report. But a rapid test done with discipline can change how a lab serves patients, doctors and hospitals. Corporate hospitals need faster triage. Pathology chains need standardised infectious disease menus. Standalone labs need services that increase walk-ins and doctor confidence. The future of infectious disease diagnostics will not be only about bigger instruments. It will be about faster, reliable, well-governed decisions. And rapid testing, when used responsibly, can become that first decision layer. 👉👉Please like , share and subscribe‼️ #RapidDiagnostics #IVD #InfectiousDiseaseTesting #PathologyLabs #Diagnostics #HealthcareInnovation #Dengue #Malaria #HospitalLabs ASSOCIATION OF DIAGNOSTICS MANUFACTURERS OF INDIA